InsiderTrades

Form 4 for IGC IGC Pharma, Inc.

Accepted 2026-02-04 00:00:00 ET · period of report 2026-02-03 · accession 0001185185-26-000411 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2026-02-04 2026-02-03 IGC Mukunda Ram CEO, Dir M - OptEx $0.00 +50.0K 860.8K +6% $0
DMI 2026-02-04 2026-02-03 IGC Mukunda Ram CEO, Dir A - Grant $0.00 +83.3K 66.7K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-03 M A 50,000 $0.00 860,752 I BY SPOUSE — — (F1) On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to immediate vesting.
2 Derivative Restricted Stock Units 2026-02-03 A A 16,667 $0.00 16,667 I BY SPOUSE — · — to — 16,667 Common Stock (F2) On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to vesting on March 31, 2026. (F4) Each restricted stock unit represents a right to receive one share of IGC common stock.
3 Derivative Restricted Stock Units 2026-02-03 A A 66,666 $0.00 66,666 I BY SPOUSE — · — to — 66,666 Common Stock (F3) On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to vesting equally over two years starting on March 31, 2026. (F4) Each restricted stock unit represents a right to receive one share of IGC common stock.